US and India reach trade deal, Astrazeneca shares move to NYSE

February 2, 2026 - 23:17

A significant trade agreement between the United States and India has captured market attention, signaling a potential deepening of economic ties between the two nations. While specific details of the pact were not immediately disclosed, the development is viewed as a positive step in resolving longstanding trade disputes and fostering increased cooperation.

In a separate major corporate move, pharmaceutical giant AstraZeneca has officially commenced trading on the New York Stock Exchange. The shift from the Nasdaq is seen as a strategic effort to enhance the company's visibility and attract a broader base of investors in the world's largest equity market. This transition marks a significant new chapter for the drugmaker.

Meanwhile, the retail sector is undergoing a leadership transition as two of America's largest chains, Target and Walmart, usher in new chief executives. These simultaneous changes at the top suggest a pivotal moment for the industry as companies navigate evolving consumer habits, inflationary pressures, and intense competition. The market is closely watching for the strategic directions these new leaders will implement.